BDCA2 (CLEC4C) drugs for Systemic Lupus Erythematosus
2 tracked BDCA2 (CLEC4C) drugs in the Systemic Lupus Erythematosus race. The class explanation lives on the BDCA2 (CLEC4C) page; the full indication pipeline across every mechanism is on the Systemic Lupus Erythematosus page.
1 Phase 31 Phase 1
Head-to-head evidence: BCD-256 vs Litifilimab